Effect of Patent Blue V® dye on sample interference indices on the abbott architect

Annals of Clinical Biochemistry

Volumn 49, Issue 5, 2012, Pages 510-511

  McTaggart, Malcolm P ^a   Cannon, Lee P S ^a   Kearney, Edward M ^a  

^a EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; PATENT BLUE V DYE; POTASSIUM; UNCLASSIFIED DRUG;

ANAPHYLAXIS; BLOOD ANALYSIS; CORRELATION ANALYSIS; HEMOLYSIS; HUMAN; HYPERLIPIDEMIA; JAUNDICE; LETTER; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PULSE OXIMETRY; SENTINEL LYMPH NODE BIOPSY; SPECTROPHOTOMETER; SURGICAL TECHNIQUE; ULTRAVIOLET SPECTROPHOTOMETRY;

COLORING AGENTS; HUMANS; MICROSCOPY, ELECTRON, SCANNING TRANSMISSION; OXIMETRY; ROSANILINE DYES;

EID: 84867149142     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1258/acb.2012.012044     Document Type: Letter

References (5)

1. Darby D, Broomhead C. Interference with serum indices measurement, but not chemical analysis, on the Roche modular by Patent Blue V. Ann Clin Biochem 2008;45:289-92
2. Xavier NL, Amaral BB, Cerski CT, et al. Sentinel lymph node identification and sampling in women with early breast cancer using 99m Tc labeled dextran 500 and patent blue V dye. Nucl Med Commun 2001;22:1109-17
3. Dewachter P, Moulton-Faivre C, Benhaijoub A, Abel-Decollogne F, Mertes PM. Anaphylactic reaction to patent blue V after sentinel lymph node biopsy. Acta Anaesthesiol Scand 2006;50:245-7
4. Haque RA, Wagner A, Whisken JA, Nasser SM, Ewan PW. Anaphylaxis to patent blue V: a case series and proposed diagnostic protocol. Allergy 2010;65:396-400
5. Hueter L, Schwarzkopf K, Karzai W. Interference of patent blue V dye with pulse oximetry and co-oximetry. Eur J Anaesthesiol 2005;22: 475-6